http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01275531-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-00
filingDate 1988-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4ad724632725ff8ebd9d37d43b9eb73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014189ea0d559121d00004c8aedf4e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd814240b4ead0ba476601aa0004270
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2647873d12ecb58241040181f9f0ec67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492c39329e1910868a0516388f9c98c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c4256b46864efb65cc2d247a76770e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c157ca59f4a8bd100042ff0ccd9738cd
publicationDate 1989-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01275531-A
titleOfInvention Suppressant of cancerous cell metastasis
abstract PURPOSE: To obtain a suppressant of cancerous cell metastatsis, extremely excellently suppressing metastasis of cancerous cell, having extremely low cell disorder, comprising nojirimycin, mojirimycin sulfite adduct, etc., as an active ingredient. n CONSTITUTION: A suppressant of cancerous cell metastatsis containing nojirimycin (5-amino-5-deoxy-D-glucopyranose) shown by the formula (Z is OH, SO 3 H or H; one of R 1 and R 2 is OH and the other is H), nojirimycin sulfide adduct, nojirimycin B (5-amino-5-deoxy-D-mannopyranose), nojirimycin B sulfite adduct of 1-deoxynojirimycin as an active ingredient. The suppressant can extremely raise carcinostatic effects by simultaneous administration with an existing carcinostatic agent and using the suppressant during surgical therapy or radiation therapy and 100gW3,000mg suppressant is administered once or several time daily. n COPYRIGHT: (C)1989,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0328111-A2
priorityDate 1988-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44387838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226507958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471678666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415825084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395270

Total number of triples: 38.